NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding NextCure, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 45 | 44 | −1 |
| Shares | 13.4M | 13.3M | −124.9K (−0.9%) |
| Value | $18.9M | $19.6M | +$754.7K (+4.0%) |
New holders (5)
Institutions that held NextCure, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tang Capital Management LLC | 400,000 | $592.0K | 0.09% |
| BML Capital Management, LLC | 306,465 | $453.6K | 0.39% |
| Marquette Asset Management, LLC | 51,425 | $76.1K | 0.02% |
| Group One Trading, L.P. | 846 | $1.25K | 0.00% |
| Royal Bank of Canada | 11 | $0 | 0.00% |
Sold out (6)
Institutions that held NextCure, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Cardiff Park Advisors, LLC | 262,000 | $369.4K |
| Two Sigma Investments, LP | 33,855 | $47.7K |
| Jane Street Group, LLC | 23,742 | $33.5K |
| Virtu Financial LLC | 19,580 | $28.0K |
| Ergoteles LLC | 17,576 | $24.8K |
| D. E. Shaw & Co., Inc. | 13,860 | $19.5K |